Skip to main content

Nutex Health, Inc. (NUTX) Stock Forecast

Data as of Sep 16, 2026

Healthcare · Current price $222.44 (+3.30%)

Consensus Target
$235.00
Upside
+53.7%
Analysts
2
Rating
Buy(2.00)

Price Target Range

Low $235.00High $235.00

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Buy
Strong Buy0
Buy2
Hold0
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

DateAnalystFirmPrice TargetUpside
Sep 18, 2024Anthony VendettiMaxim Group$45.00-79.8%

NUTX vs Sector & Market

MetricNUTXHealthcare AvgLarge Cap Avg
Analyst Rating2.002.262.42
Analyst Count2818
Target Upside+53.7%+16187.2%+19.5%
P/E Ratio16.563.7738.67

Revenue Estimates

PeriodLowAvgHigh#
2026-09-30$205M$222M$245M1
2026-12-31$221M$239M$264M2
2027-12-31$940M$947M$955M2

EPS Estimates

PeriodLowAvgHigh#
2026-09-30$3.19$3.55$4.031
2026-12-31$3.82$4.25$4.831
2027-12-31$16.79$17.55$18.621

Frequently Asked Questions

What is the analyst consensus for NUTX?

The consensus among 2 analysts covering Nutex Health, Inc. (NUTX) is Buy with an average price target of $235.00.

What is the highest price target for NUTX?

The highest price target for NUTX is $45.00, set by Anthony Vendetti at Maxim Group on 2024-09-18.

What is the lowest price target for NUTX?

The lowest price target for NUTX is $45.00, set by Anthony Vendetti at Maxim Group on 2024-09-18.

How many analysts cover NUTX?

2 analysts have issued ratings for Nutex Health, Inc. in the past 12 months.

Is NUTX a buy or sell right now?

Based on 2 analyst ratings, NUTX has a consensus rating of Buy (2.00/5) with a +53.7% upside to the consensus target of $235.00.

What are the earnings estimates for NUTX?

Analysts estimate NUTX will report EPS of $3.55 for the period ending 2026-09-30, with revenue estimated at $222M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.